Clinical trial
Effect of Loratadine/Montelukast Combination on Congestion in SAR Patients…
NCT00423995 · Organon and Co, Industry · Completed
Key facts
| NCT number | NCT00423995 |
|---|---|
| Title | Effect of Loratadine/Montelukast Combination on Congestion in SAR Patients Exposed to Pollen in an EEU (Study P04822) |
| Official title | Study of the Decongestant Effect of the Combination of Loratadine and Montelukast Compared With Placebo in SAR Subjects Exposed to Pollen in an Environmental Exposure Unit |
| Lead sponsor | Organon and Co, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Seasonal Allergic Rhinitis |
| Intervention type | Drug |
| Interventions | Loratadine/montelukast combination |
| Enrollment | 379 |
| Start date | Nov 1, 2006 |
| Primary completion | Mar 1, 2007 |
| Completion | Mar 10, 2007 |
| First posted | Jan 18, 2007 |
| Last update posted | Aug 15, 2024 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: